BioSpace News Archive

Poxel has also established a Japanese subsidiary in Tokyo

Event to Help Boost Multiple Myeloma Awareness and Planning

According to a new series of reports by iData Research, the global spine market is valued at over $14.4 billion USD and is projected to approach $18 billion by 2023. Researched regions include the United States, 15 countries in Europe, 3 countries in Latin America, and 5 countries in Asia-Pacific.

InMed Pharmaceuticals Inc. is a fully integrated, cannabinoid-based biopharmaceutical company that leverages its proprietary platform technologies to develop novel therapeutics for the treatment of diseases with high unmet medical needs

Over the past ten months the Company has engaged and worked with contractors, consultants and various state and municipal regulators in order to successfully gain licensing and approvals for facilities that manufacture CBD- and THC-infused products in the State of Colorado.

Seasoned industry leader to provide expert counsel to help guide strategic growth of IFM Therapeutics, LLC

4C Medical Technologies, Inc. today announced that its AltaValve™, a transcatheter mitral valve replacement (TMVR) technology, will be highlighted in the following presentations at the Transcatheter Cardiovascular Therapeutics (TCT) meeting held September 21-25, 2018 in San Diego, CA

Nimacimab, also known as RYI-018 or JNJ-2463, is a negative-allosteric modulating antibody targeting the cannabinoid 1 recepto

entrotech life sciences, inc., an organization focused on helping healthcare professionals save lives, today announced the launch of its PrevahexCHX™ Antimicrobial Dressing, the first in a suite of PrevahexCHX products designed to help prevent catheter-related bloodstream infections (CRBSIs) and surgical site infections (SSIs).

Today, Cronos Group Inc. (“Cronos Group” or the “Company”) is pleased to announce the launch of its second cannabis brand for the domestic recreational market, Spinach™.